John D. Schreier

1.2k total citations
10 papers, 377 citations indexed

About

John D. Schreier is a scholar working on Organic Chemistry, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, John D. Schreier has authored 10 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Cognitive Neuroscience. Recurrent topics in John D. Schreier's work include Sleep and Wakefulness Research (4 papers), Sleep and related disorders (3 papers) and Circadian rhythm and melatonin (3 papers). John D. Schreier is often cited by papers focused on Sleep and Wakefulness Research (4 papers), Sleep and related disorders (3 papers) and Circadian rhythm and melatonin (3 papers). John D. Schreier collaborates with scholars based in United States. John D. Schreier's co-authors include Izzat T. Raheem, Paul J. Coleman, Peter E. Maligres, Shane W. Krska, Christopher D. Cox, John J. Renger, Michael J. Breslin, Jing Li, C. Meacham Harrell and Christopher J. Winrow and has published in prestigious journals such as Angewandte Chemie International Edition, Neuropharmacology and Tetrahedron Letters.

In The Last Decade

John D. Schreier

10 papers receiving 365 citations

Peers

John D. Schreier

OC

MB

CN

EAS

ECP

Cynthia D. Jesudason United States

David A. Perrey United States

Kentaro Rikimaru Japan

Marinella Antolini Italy

Michelle Wennerholm United States

Megumi Shibahara Japan

Dirk Behnke Germany

Luigi Stasi Italy

Wai N. Chan United Kingdom

Lynn Resnick United States

Cynthia D. Jesudason United States

John D. Schreier

187 ×1.4

OC

182 ×1.4

MB

116 ×0.9

CN

80 ×0.7

EAS

72 ×0.7

ECP

Citations per year, relative to John D. Schreier John D. Schreier (= 1×) peers Cynthia D. Jesudason

Countries citing papers authored by John D. Schreier

Since Specialization

Citations

This map shows the geographic impact of John D. Schreier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Schreier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Schreier more than expected).

Fields of papers citing papers by John D. Schreier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Schreier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Schreier. The network helps show where John D. Schreier may publish in the future.

Co-authorship network of co-authors of John D. Schreier

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Schreier. A scholar is included among the top collaborators of John D. Schreier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Schreier. John D. Schreier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

McGaughey, Georgia B., Christopher I. Bayly, Christopher D. Cox, et al.. (2014). Shaping suvorexant: application of experimental and theoretical methods for driving synthetic designs. Journal of Computer-Aided Molecular Design. 28(1). 5–12. 12 indexed citations

2.

Smith, Sean M., Jason M. Uslaner, Christopher D. Cox, et al.. (2012). The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey. Neuropharmacology. 64. 215–223. 70 indexed citations

3.

Maligres, Peter E., Jing Li, Shane W. Krska, John D. Schreier, & Izzat T. Raheem. (2012). CO Cross‐Coupling of Activated Aryl and Heteroaryl Halides with Aliphatic Alcohols. Angewandte Chemie International Edition. 51(36). 9071–9074. 73 indexed citations

4.

Raheem, Izzat T., Michael J. Breslin, Christine Fandozzi, et al.. (2012). Discovery of tetrahydropyridopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia. Bioorganic & Medicinal Chemistry Letters. 22(18). 5903–5908. 25 indexed citations

5.

Maligres, Peter E., Jing Li, Shane W. Krska, John D. Schreier, & Izzat T. Raheem. (2012). CO Cross‐Coupling of Activated Aryl and Heteroaryl Halides with Aliphatic Alcohols. Angewandte Chemie. 124(36). 9205–9208. 16 indexed citations

6.

Winrow, Christopher J., Anthony L. Gotter, Christopher D. Cox, et al.. (2011). Pharmacological characterization of MK-6096 – A dual orexin receptor antagonist for insomnia. Neuropharmacology. 62(2). 978–987. 109 indexed citations

7.

Raheem, Izzat T., John D. Schreier, & Michael J. Breslin. (2011). Efficient synthesis of highly functionalized tetrahydropyridopyrimidines by a novel three-component coupling reaction. Tetrahedron Letters. 52(30). 3849–3852. 4 indexed citations

8.

Coleman, Paul J., John D. Schreier, Georgia B. McGaughey, et al.. (2010). Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(7). 2311–2315. 12 indexed citations

9.

Coleman, Paul J., John D. Schreier, Anthony J. Roecker, et al.. (2010). Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat. Bioorganic & Medicinal Chemistry Letters. 20(14). 4201–4205. 21 indexed citations

10.

Roecker, Anthony J., Paul J. Coleman, Swati P. Mercer, et al.. (2007). Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5-dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP. Bioorganic & Medicinal Chemistry Letters. 17(20). 5677–5682. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact